Branch-Elliman W, Ferguson R, Doros G, Woods P, et al. Subcutaneous sarilumab for the treatment of hospitalized patients with moderate
to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One 2022;17:e0263591.
PMID: 35213547